Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Dec 22 424B3 Prospectus supplement
- 14 Nov 22 EFFECT Notice of effectiveness
- 10 Nov 22 424B3 Prospectus supplement
- 4 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
24 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Aug 22 S-4 Registration of securities issued in business combination transactions
KANT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of Yumanity Therapeutics, Inc. of our report dated March 24, 2022 relating to the financial statements of Yumanity Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
October 24, 2022